INTERACTIONS STUDY OF THE LOW-MOLECULAR-WEIGHT HEPARINOID ORG-10172 (LOMOPARAN) AND ACETYLSALICYLIC-ACID IN HEALTHY MALE-VOLUNTEERS

被引：0
|
作者：
DEBOER, A
DANHOF, M
COHEN, AF
MAGNANI, HN
BREIMER, DD
机构：
[1] CTR HUMAN DRUG RES,2300 RC LEIDEN,NETHERLANDS
[2] LEIDEN STATE UNIV,CTR BIOPHARMACEUT SCI,DIV PHARMACOL,2312 AV LEIDEN,NETHERLANDS
[3] ORGANON INT BV,OSS,NETHERLANDS
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1990年 / 183卷 / 02期
关键词：
D O I：
10.1016/0014-2999(90)93567-A
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：641 / 641
页数：1
相关论文
共 39 条
  • [31] HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN BUT NOT HIRUDIN STIMULATE PLATELET-AGGREGATION IN WHOLE-BLOOD FROM ACETYLSALICYLIC-ACID TREATED HEALTHY-VOLUNTEERS
    CHEN, JH
    KARLBERG, KE
    SYLVEN, C
    THROMBOSIS RESEARCH, 1991, 63 (03) : 319 - 329
  • [32] A DOUBLE-BLIND RANDOMIZED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID VERSUS UNFRACTIONATED HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS IN PATIENTS WITH THROMBOTIC STROKE
    TURPIE, AGG
    LEVINE, MN
    POWERS, P
    GINSBERG, JG
    JAY, R
    KLIMEK, M
    LECLERC, J
    COTE, R
    NEEMEH, J
    GEERTS, W
    HIRSH, J
    GENT, M
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 753 - 753
  • [33] PROTECTIVE EFFECTS OF OMEPRAZOLE AGAINST LOW-DOSE ACETYLSALICYLIC-ACID - AN ENDOSCOPIC CONTROLLED DOUBLE-BLIND-STUDY IN HEALTHY-VOLUNTEERS
    SIMON, B
    ELSNER, H
    MULLER, P
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1995, 45-1 (06): : 701 - 703
  • [34] PROPHYLACTIC DOSES OF A LOW-MOLECULAR-WEIGHT HEPARIN (NADROPARINE) - CHRONOPHARMACOLOGICAL STUDY AFTER SUBCUTANEOUS ADMINISTRATION TO HEALTHY-VOLUNTEERS
    MISMETTI, P
    PERPOINT, B
    LAPORTESIMITSIDIS, S
    TARDYPONCET, B
    REYNAUD, J
    CHERRAH, Y
    OLLAGNIER, M
    QUENEAU, P
    DECOUSUS, H
    THERAPIE, 1992, 47 (06): : 557 - 560
  • [35] A COMPARATIVE-STUDY OF 3 LOW-MOLECULAR-WEIGHT HEPARINS (LMWH) AND UNFRACTIONATED HEPARIN (UFH) IN HEALTHY-VOLUNTEERS
    ERIKSSON, BI
    SODERBERG, K
    WIDLUND, L
    WANDELI, B
    TENGBORN, L
    RISBERG, B
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 656 - 656
  • [36] A COMPARATIVE-STUDY OF 3 LOW-MOLECULAR-WEIGHT HEPARINS (LMWH) AND UNFRACTIONATED HEPARIN (UH) IN HEALTHY-VOLUNTEERS
    ERIKSSON, BI
    SODERBERG, K
    WIDLUND, L
    WANDELI, B
    TENGBORN, L
    RISBERG, B
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (03) : 398 - 401
  • [37] COMPARISON OF LOW-MOLECULAR-WEIGHT HEPARINS AND UNFRACTIONATED HEPARIN AFTER SUCCESSIVE SUBCUTANEOUS ADMINISTRATION - A RANDOMIZED CONTROLLED-STUDY IN HEALTHY-VOLUNTEERS
    PINDUR, G
    HEIDEN, M
    KOHLER, M
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1993, 43-1 (05): : 542 - 547
  • [38] BIOAVAILABILITY AND PHARMACOKINETICS OF A NEW LOW-MOLECULAR-WEIGHT HEPARIN (RO-11) - A 3-WAY CROSS-OVER STUDY IN HEALTHY-VOLUNTEERS
    FALKON, L
    SAENZCAMPOS, D
    ANTONIJOAN, R
    MARTIN, S
    BARBANOJ, M
    FONTCUBERTA, J
    THROMBOSIS RESEARCH, 1995, 78 (01) : 77 - 86
  • [39] CHRONO-PHARMACOLOGICAL STUDY OF ONCE-DAILY CURATIVE DOSE OF A LOW-MOLECULAR-WEIGHT HEPARIN (200 IU ANTIXA/KG OF DALTEPARIN) IN 10 HEALTHY-VOLUNTEERS
    MISMETTI, P
    REYNAUD, J
    TARDYPONCET, B
    LAPORTESIMITSIDIS, S
    SCULLY, M
    GOODWYN, C
    QUENEAU, P
    DECOUSUS, H
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (02) : 660 - 666
1234